AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results - Nasdaq

AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results  Nasdaq

Announces name change to Beyond Air™. Completed uplisting to the NASDAQ and $7.96 million PIPE financing. Anticipate PMA submission in the third.